{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:58:47Z","timestamp":1769601527817,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clml.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T00:00:23Z","timestamp":1499817623000},"page":"e65-e69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics of Vitamin B12 Deficiency in Patients With Plasma Cell Disorders"],"prefix":"10.1016","volume":"17","author":[{"given":"Caitlyn","family":"Braschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.0954-6820.1962.tb07143.x","article-title":"Myeloma and pernicious anaemia","volume":"172","author":"Larsson","year":"1962","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.clml.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jcp.20.5.699","article-title":"Incidence and pathogenesis of megaloblastic erythropoiesis in multiple myeloma","volume":"20","author":"Hoffbrand","year":"1967","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clml.2017.07.001_bib3","first-page":"38","article-title":"Multiple myeloma and pernicious anemia, (case report)","volume":"66","author":"Gomez","year":"1970","journal-title":"W\u00a0V Med J"},{"key":"10.1016\/j.clml.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5694\/j.1326-5377.1969.tb92131.x","article-title":"Multiple myeloma and pernicious anaemia","volume":"1","author":"Fraser","year":"1969","journal-title":"Med J Aust"},{"key":"10.1016\/j.clml.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1","article-title":"Pernicious anemia and subsequent cancer. A population-based cohort study","volume":"71","author":"Hsing","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.cgh.2015.05.040","article-title":"Cancer risk following pernicious anemia in the US elderly population","volume":"13","author":"Murphy","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1989.169","article-title":"Cancer risk following pernicious anaemia","volume":"59","author":"Brinton","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clml.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/cncr.20441","article-title":"Prevalence of vitamin B12 deficiency in\u00a0patients with plasma cell dyscrasias: a retrospective review","volume":"101","author":"Baz","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.07.001_bib10","first-page":"249","article-title":"Low cobalamin (vitamin B12) levels in multiple myeloma: a retrospective study","volume":"61","author":"Vlasveld","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.clml.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"493697","DOI":"10.1155\/2011\/493697","article-title":"Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney)","volume":"2011","author":"Stringer","year":"2011","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.clml.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"F22","DOI":"10.1152\/ajprenal.00385.2005","article-title":"The kidney in vitamin B12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins","volume":"291","author":"Birn","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clml.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"F408","DOI":"10.1152\/ajprenal.00206.2000","article-title":"Megalin is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B12","volume":"282","author":"Birn","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clml.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.clml.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(03)12457-9","article-title":"Serum test for assessment of patients with Bence Jones myeloma","volume":"361","author":"Bradwell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2017.07.001_bib17","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","author":"Drayson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.nutres.2015.10.003","article-title":"Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke","volume":"36","author":"Spence","year":"2016","journal-title":"Nutr Res"},{"key":"10.1016\/j.clml.2017.07.001_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3945\/ajcn.113.061234","article-title":"Modeling a methylmalonic acid\u2013derived change point for serum vitamin B-12 for adults in NHANES","volume":"98","author":"Bailey","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clml.2017.07.001_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jclinpath-2015-203502","article-title":"Laboratory assessment of vitamin B12 status","volume":"70","author":"Harrington","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clml.2017.07.001_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.exger.2017.05.017","article-title":"Vitamin B12 deficiency might be related to sarcopenia in older adults","volume":"95","author":"Bulut","year":"2017","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.clml.2017.07.001_bib22","first-page":"305","article-title":"Low borderline levels of serum vitamin B12 may predict cognitive decline in elderly hip fracture patients","volume":"19","author":"Mizrahi","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.clml.2017.07.001_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2003.1.62","article-title":"Update on cobalamin, folate, and homocysteine","volume":"2003","author":"Carmel","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2017.07.001_bib24","first-page":"1425","article-title":"Update on vitamin B12 deficiency","volume":"83","author":"Langan","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clml.2017.07.001_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ajh.2830340205","article-title":"Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations","volume":"34","author":"Lindenbaum","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2017.07.001_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00000441-199411000-00004","article-title":"Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency","volume":"308","author":"Matchar","year":"1994","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clml.2017.07.001_bib27","doi-asserted-by":"crossref","first-page":"313S","DOI":"10.3945\/ajcn.111.013243","article-title":"Biomarkers of vitamin B-12 status in NHANES: a roundtable summary","volume":"94","author":"Yetley","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clml.2017.07.001_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.nutr.19.1.357","article-title":"Vitamin B12 deficiency in the elderly","volume":"19","author":"Baik","year":"1999","journal-title":"Annu Rev Nutr"},{"issue":"2 Suppl 1","key":"10.1016\/j.clml.2017.07.001_bib29","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2017.07.001_bib30","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/archinte.162.19.2251-a","article-title":"Metformin-associated vitamin B12 deficiency","volume":"162","author":"Andr\u00e8s","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clml.2017.07.001_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2337\/dc11-1582","article-title":"Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements","volume":"35","author":"Reinstatler","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clml.2017.07.001_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.amjcard.2004.06.047","article-title":"Association of aspirin use with vitamin B12 deficiency (results of the BACH study)","volume":"94","author":"van Oijen","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clml.2017.07.001_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jclinepi.2003.08.015","article-title":"A\u00a0case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B 12 deficiency in older adults","volume":"57","author":"Valuck","year":"2004","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clml.2017.07.001_bib34","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2017.07.001_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13312-015-0642-x","article-title":"Effect of pre-treatment nutritional status, folate and vitamin B12 levels on induction chemotherapy in children with acute lymphoblastic leukemia","volume":"52","author":"Tandon","year":"2015","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.clml.2017.07.001_bib36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1600-0609.2005.00441.x","article-title":"Macrocytosis associated with monoclonal gammopathy","volume":"75","author":"Horstman","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2017.07.001_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2017.07.001_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.beha.2005.01.008","article-title":"Multiple myeloma: clinical features and indications for therapy","volume":"18","author":"Dispenzieri","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2017.07.001_bib39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3109\/0886022X.2015.1052980","article-title":"The association of serum-free light-chain levels with markers of renal function","volume":"37","author":"Erdem","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.clml.2017.07.001_bib40","doi-asserted-by":"crossref","first-page":"c42","DOI":"10.1159\/000083132","article-title":"Cellular uptake of vitamin B12 in patients with chronic renal failure","volume":"99","author":"Obeid","year":"2005","journal-title":"Nephron Clin Pract"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016306188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016306188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:44Z","timestamp":1761870704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265016306188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2152265016306188"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2017.07.001","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Vitamin B12 Deficiency in Patients With Plasma Cell Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}